Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism: Follow-up results

Inflammation

Volumn 37, Issue 4, 2014, Pages 1186-1190

  Halici, Bilal ^a   Sarinc Ulasli, Sevinc ^a   Günay, Ersin ^a   Nural, Serkan ^b   Sen, Serkan ^a   Akar, Olcay ^a   Celik, Sefa ^a   Unlu, Mehmet ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b CIZRE STATE HOSPITAL   (Turkey)

Author keywords

ADMA; IL 6; oxidative stress; pulmonary thromboembolism; TNF

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; OXIDIZING AGENT; TUMOR NECROSIS FACTOR ALPHA; ARGININE; IL6 PROTEIN, HUMAN; N,N-DIMETHYLARGININE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PROSPECTIVE STUDY; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; ANALOGS AND DERIVATIVES; ANOXIA; INFLAMMATION; METABOLISM; PATHOLOGY; RISK FACTOR;

TOSCANA VIRUS;

ADULT; AGED; ANOXIA; ANTIOXIDANTS; ARGININE; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904752503     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9844-y     Document Type: Article

References (24)

1. Wicki, J., A. Perrier, T.V. Perneger, H. Bounameaux, and A.F. Junod. 2000. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 84: 548-552.
2. Günay, E., S. Sarinc Ulasli, E. Kacar, B. Halici, E. Unlu, K. Tünay, et al. 2014. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? Clin Respir J 8(1): 33-40. doi:10.1111/crj.12031.
3. Girard, P., D. Musset, F. Parent, S. Maitre, C. Phlippoteau, and G. Simonneau. 1999. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 116: 903-908. (Pubitemid 29491857)
4. Muhl, D., R. Furedi, J. Cristofari, S. Ghosh, L. Bogár, B. Borsiczki, et al. 2006. Evaluation of oxidative stress in the thrombolysis of pulmonary embolism. J Thromb Thrombolysis 22: 221-228. (Pubitemid 44857784)
5. Sies, H. 1997. Oxidative stress: oxidants and antioxidants. Exp Physiol 82: 291-295. (Pubitemid 27182306)
6. Valdez, L.B., S.L. Arnaiz, J. Bustamante, S. Alvarez, L.E. Costa, and A. Boveris. 2000. Free radical chemistry in biological systems. Biol Res 33: 65-70.
7. Nijveldt, R.J., T. Teerlink, C. van Guldener, H.A. Prins, A.A. van Lambalgen, C.D. Stehouwer, J.A., et al. 2003. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18: 2542-2550. (Pubitemid 37483787)
8. Vallance, P., and J. Leiper. 2004. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24: 1023-1030. (Pubitemid 38737826)
9. Nural, S., E. Günay, B. Halici, S. Celik, and M. Ünlü. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66-74.
10. Buǧdayci, G., and E. Serin. 2005. Asimetrik Dimetilarginin (ADMA). Düzce Tip Fakultesi Dergisi 2: 36-41.
11. Erel, O. 2005. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38: 1103-1111.
12. Erel, O. 2004. A novel automated directmeasurementmethod for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37: 277-285. (Pubitemid 38314881)
13. Ovechkin, A.V., D. Lominadze, K.C. Sedoris, T.W. Robinson, S.C. Tyagi, and A.M. Roberts. 2007. Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 113: 1-12. (Pubitemid 46825684)
14. Re, G., C. Lanzarini, I. Vaona, M. Pazzaglia, G. Palareti, L. Bassein, and C. Guarnieri. 1998. Systemically circulating oxidative species in human deep venous thrombosis. Eur J Emerg Med 5: 9-12.
15. Dias-Junior, C.A., E.M. Neto-Neves, M.F. Montenegro, and J.E. Tanus-Santos. 2010. Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. Nitric Oxide 23: 284-288.
16. Sousa-Santos, O., E.M. Neto-Neves, K.C. Ferraz, C.S. Ceron, E. Rizzi, R.F. Gerlach, et al. 2012. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism. Naunyn Schmiedebergs Arch Pharmacol 385: 685-696.
17. Fox, E.A., and S.R. Kahn. 2005. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 94: 362-365. (Pubitemid 41122491)
18. Marchena Yglesias, P.J., J.A. Nieto Rodríguez, S. Serrano Martínez, O. Belinchón Moya, A. Cortés Carmona, A. Díaz de Tuesta, et al. 2006. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Interna 23: 105-110.
19. Jezovnik, M.K., and P. Poredos. 2010. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29: 226-231.
20. Altuntai, M., F. Atalay, M. Can, R. Altin, and M. Tor. 2011. Serum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolism. Mediat Inflamm 2011: 215057.
21. Bakr, A., O. Pak, A. Taye, F. Hamada, R. Hemeida, W. Janssen, et al. 2013. Effects of dimethylarginine dimethylaminohydrolase-1 overexpression on the response of the pulmonary vasculature to hypoxia. Am J Respir Cell Mol Biol 49: 491-500.
22. Millatt, L.J., G.S. Whitley, D. Li, J.M. Leiper, H.M. Siragy, R.M. Carey, et al. 2003. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation 108: 1493-1498. (Pubitemid 37176457)
23. Pei, Y., P. Ma, X. Wang, W. Zhang, F. Zheng, et al. 2011. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism. Eur J Pharmacol 666: 165-172.
24. Pullamsetti, S.S., R. Savai, M.B. Schaefer, J. Wilhelm, H.A. Ghofrani, N. Weissmann, et al. 2011. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases. Circulation 123: 1194-1204.